2m 2m 2m 2m 2m 2m 2m
SAB BIOTHERAP (SABS)
NASDAQ
$3.38-$0.10 (-3.02%)
Price as of Jun 03, 2026 5:54 PM EDT- $275.3MMarket Cap
- 87.10%1-Year Change
- BiotechnologyIndustry
SAB BIOTHERAP (SABS)
$3.38-$0.10 (-3.02%)
SABS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.48 | ||
Change | +$0.04 (+1.16%) | ||
Open | $3.45 | ||
High | $3.54 | ||
Low | $3.41 | ||
Previous Close | $3.44 | ||
Volume | 474,319 | ||
30-Day Average Volume | 1,026,168 | ||
1-Week Change | -8.66% | ||
1-Month Change | 0.29% | ||
1-Year Change | 87.10% | ||
3-Year Change | -62.03% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 76.5M | ||
Total Assets | $248.5M | ||
Market Cap | $275.3M | ||
Enterprise Value | $254.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$18.9M | ||
Free Cash Flow | -$15.3M | ||
EBIT | -$18.9M | ||
EBITDA | -$18.1M | ||
Net Working Capital | N/A | ||
EPS | -$0.35 | ||
Enterprise Value/EBITDA | -14 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -10 | ||
PEG | 0 | ||
Price/Free Cash Flow | -18 | ||
Price/Operating Cash Flow | -19 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 01/05/2024 | ||
Earnings & Revenue